Liver-directed targeting of PD-L1 with RO7191863, A locked nucleic acid, in chronic hepatitis B: First report of phase 1 tolerability, pharmacokinetics, and pharmacodynamics

Authors
Category Primary study
ConferenceHepatology
Year 2021
This article has no abstract
Epistemonikos ID: 4c2f074c06edde2ab18cf2516d189768e775454f
First added on: Apr 30, 2026